FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18063411000001105: Plavix 75mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62153101000001119 Plavix 75mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62153201000001114 Plavix 75mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Plavix 75mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Is a Clopidogrel 75mg tablets false Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Is a Clopidogrel 75mg tablets true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Is a Product containing precisely clopidogrel bisulfate 75 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has active ingredient Clopidogrel bisulfate false Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has specific active ingredient Clopidogrel true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clopidogrel false Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Is a Plavix true Inferred relationship Existential restriction modifier
Plavix 75mg tablets (Lexon (UK) Ltd) Has basis of strength substance Clopidogrel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Plavix 75mg tablets (Lexon (UK) Ltd) 28 tablet Has AMP True Plavix 75mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start